Agios Pharmaceuticals ($AGIO) Insider Trading & Smart Money Activity

Agios Pharmaceuticals, Inc. · Biotechnology · Latest filing Aug 20, 2026

Agios Pharmaceuticals, Inc. ($AGIO) has 10 insider trades, 1 congress trade and 9 13F position changes on file. Insiders filed 10 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
1
13F moves on file
9
Analyst ratings on file
0

AGIO insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 6 / 3
Q3 2026 0 0 1 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AGIO insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Congress Gilbert Ray Cisneros Jr. Purchase $1,001 - $15,000 +1.9%+1.0% —
Insider Cynthia Smith Buy (Option exercise) 2.82K sh +6.0%+17.3% Read
Insider David Scadden Buy (Grant or award) 14.95K sh +6.0%+17.3% Read
Insider Sarah GheuensChief Medical Officer Buy (Grant or award) 3K sh +6.0%+17.3% Read
Insider Jacqualyn Fouse Buy (Grant or award) 14.95K sh +6.0%+17.3% Read
Insider Rahul Ballal Buy (Grant or award) 14.95K sh +6.0%+17.3% Read
Insider Jay Backstrom Buy (Grant or award) 14.95K sh +6.0%+17.3% Read
Insider Owen Adams Catherine Sell (Option exercise) 1.98K sh +10.3%+27.4% —
Insider Owen Adams Catherine Buy (Option exercise) 1.98K sh +10.3%+27.4% —
Insider Jeffrey Capello Sell (Option exercise) 1.98K sh +10.3%+27.4% —
Insider Jeffrey Capello Buy (Option exercise) 1.98K sh +10.3%+27.4% —
13F Susquehanna International Group Added +202.52K sh $51.14M -0.1%+13.0% —
13F Susquehanna International Group Added +202.52K sh $38.05M -0.1%+13.0% —
13F Farallon Capital Management Added +524.50K sh $216.11M -0.1%+13.0% —
13F D. E. Shaw Added +843.98K sh $101.94M -0.1%+13.0% —
13F Simplex Trading Added +31.25K sh $1.42M +0.2%+10.8% —
13F Group One Trading Added +6.67K sh $6.59M -0.9%+2.4% —
13F Jane Street Group Reduced -435.81K sh $26.05M -2.4%+1.1% —
13F Jane Street Group Reduced -435.81K sh $19.39M -2.4%+1.1% —
13F Dekabank Deutsche Girozentrale Sold out -40K sh +4.4%-0.3% —

1W / 1M / 6M = how AGIO moved from the trade or filing date.

Insider trading in AGIO: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Cynthia Smith 1 — Jun 18, 2026
David Scadden 1 — Jun 18, 2026
Sarah Gheuens Chief Medical Officer 1 — Jun 18, 2026
Jacqualyn Fouse 1 — Jun 18, 2026
Rahul Ballal 1 — Jun 18, 2026
Jay Backstrom 1 — Jun 18, 2026
Owen Adams Catherine 2 — Jun 13, 2026
Jeffrey Capello 2 — Jun 13, 2026

Members of Congress trading AGIO

Institutions moving AGIO (13F)

Frequently asked questions

What is the latest insider trade in AGIO?

Cynthia Smith filed a buy (option exercise) of 2.82K sh on Jun 18, 2026.

Which members of Congress traded AGIO?

1 disclosed trade by Gilbert Ray Cisneros Jr.. The latest was on Aug 20, 2026.

Which institutions changed their AGIO positions?

Recent 13F filers moving the stock include Susquehanna International Group, Jane Street Group, Farallon Capital Management, D. E. Shaw and Simplex Trading.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text